Xeros Technology : Directorate changes

Directorate changes

Released : 12 Feb 2019 07:00

RNS Number : 6939P

Xeros Technology Group plc 12 February 2019

12 February 2019

Xeros Technology Group plc

Directorate changes

Xeros Technology Group plc (AIM: XSG, 'Xeros', 'the Group'), the developer and provider of water saving technologies with multiple commercial applications, today announces that John Samuel has resigned as non-executive Chairman with immediate effect. David Armfield, who joined the Board in June 2018, has been appointed interim non-executive Chairman.

Separately David Baynes, a director of IP Group plc, joins the Board as a non-executive director today. He is a Chartered Accountant and will Chair the Audit Committee.

David Graham Baynes, aged 55, is currently Chief Operating Officer at IP Group plc and has been on its Board since March 2014. He was previously a co-founder and the CEO of AIM-listed Fusion IP plc and was also a co-founder, CEO and CFO of Toad plc (now 21st Century Technology plc). David also worked at Celsis International plc from its incorporation to its flotation on the full list of the London Stock Exchange and was previously CFO of Codemasters Limited, at the time, the UK's largest privately-owned games company.

David Armfield, interim non-executive Chairman, commented:

"On behalf of the Board, I would like to thank John for his considerable contribution as Chairman since the business listed in March 2014. It has progressed from early stage technology development to its current position of having multiple proprietary applications in the process of commercialisation. As he steps down in order to devote more time to his other executive and non-executive Board roles - we wish him well for the future. I would also like to welcome David to the Board who brings with him a huge amount of experience in growth companies, both private and public."

Enquiries:

AIM Rules for Companies Schedule 2 (g) information

David Baynes, holds or has held the following directorships in the five years preceding his appointment to the Xeros Technology Group Plc Board.

Current directorships:

Director, IPG USA (LP) Limited Director, Imperial Innovations Limited

Director, Touchstone Innovations Investments Limited Director, Imperial College Company Maker Limited Director, Innovations Limited Partner Ltd

Director, Touchstone Innovations Plc Director, IP2IPO Asia-Pacific Limited Director, IP2IPO US Partners Limited Director, IP2IPO Americas Limited Director, IP2IPO Carry Partner Limited Director, IP2IPO Portfolio (GP) Limited Director, Top Technology Ventures Limited Finance Director, IP2IPO FI Limited Director, Intelligent Ultrasound Group Plc Finance Director, IP2IPO Limited

Finance Director, North East Technology (GP) Limited Finance Director, IP Venture Fund (GP) Limited Director, IP Group Plc

Director, MedaPhor Limited Director, Morvus

Director, Demasq Limited Director, Phase Focus Limited Director, Fusion IP Nottingham Limited Director, Fusion IP Two Limited Director, Fusion IP Cardiff Limited

Finance Director, Biofusion Licensing (Sheffield) Limited Director, Fusion IP Limited

Director, Out Of The Blue Consulting Limited Director, Fusion IP Sheffield Limited

Previous directorships, last 5 years:

Director, Arthurian Life Sciences Limited Director, Rhedyn Limited

Director, Wound Genetics Limited Director, Proflu Limited

Director, Wound Genetics Therapeutics Limited Director, Wound Genetics Prognostics Limited Director, Rheometrix Microsystems Limited Director, Perlemax Limited

Director, Medipex Limited Director, Mesuro Limited Director, Magnomatics Ltd Director, Biohydrogen Limited Director, Alesi Surgical Limited Director, Medella Therapeutics Limited CEO, Mantelum Limited

Director, Diurnal Limited

November 2018 - Present February 2018 - Present February 2018 - Present February 2018 - Present February 2018 - Present December 2017 - Present February 2017 - Present December 2016 - Present November 2016 - Present September 2016 - Present September 2016 - Present August 2015 - Present September 2014 - Present August 2014 - Present April 2014 - Present April 2014 - Present April 2014 - Present March 2014 - Present June 2010 - Present September 2010 - Present April 2008 - Present

June 2006 - Present March 2008 - Present March 2008 - Present November 2006 - Present September 2006 - Present November 2004 - Present March 2003 - Present January 2003 - PresentJuly 2013 - July 2015

March 2013 - March 2016

November 2012 - September 2016

November 2012 - July 2016

November 2012 - September 2016

November 2012 - September 2016

April 2012 - September 2016

January 2012 - September 2014

April 2011 - September 2014

September 2008 - September 2014

June 2008 - November 2014

March 2007 - September 2016

March 2007 - January 2017

February 2007 - June 2014

June 2006 - September 2016

October 2005 - October 2014

David Baynes was a Director of CellTran Limited, which developed a skin treatment for burns and chronic wounds using a patient's living cells but went into administration in May 2008 after running out of funds for product development and distribution.

There are no further disclosures to be made under Schedule 2(g) of the AIM Rules for Companies.

Notes to Editors

Xeros Technology Group plc (LN: XSG) is a platform technology company that is reinventing water intensive industrial and commercial processes.

Xeros' uses its patented XOrbTM technologies to significantly reduce the amount of water used in a number of major applications with the remaining water becoming far more efficient in either affixing or removing molecules from substrates such as fabrics and garments. The result being significant improvements in economic, operational and sustainability outcomes.

Xeros has three divisions working in the garment finishing (Textile Technologies), tanning (Tanning Technologies, branded Qualus) and cleaning/laundry (Cleaning Technologies) markets. In cleaning/laundry, the company has three applications covering domestic laundry, commercial laundry (branded "Hydrofinity") and the cleaning of high-performance workwear (branded "Marken").

For more information, please visit -http://www.xerostech.com/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contactrns@lseg.com or

visitwww.rns.com.

END

BOAFMGMZRMLGLZM